Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Strategies for Anticoagulation During Venovenous ECMO: The SAFE-ECMO Pilot Trial

NCT04997265 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT04997265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04997265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Strategies for Anticoagulation During Venovenous ECMO: The SAFE-ECMO Pilot Trial
Lead sponsor
Vanderbilt University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
May 12, 2022
Completion date
January 10, 2024
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute hypoxemic respiratory failure, anticoagulant-induced bleeding, thromboembolism